Suppr超能文献

间质干细胞和细胞衍生的细胞外囊泡可保护海马神经元免受由淀粉样β寡聚物引起的氧化应激和突触损伤。

Mesenchymal stem cells and cell-derived extracellular vesicles protect hippocampal neurons from oxidative stress and synapse damage induced by amyloid-β oligomers.

机构信息

From the Institute of Biophysics Carlos Chagas Filho.

the Institute of Medical Biochemistry Leopoldo de Meis, and.

出版信息

J Biol Chem. 2018 Feb 9;293(6):1957-1975. doi: 10.1074/jbc.M117.807180. Epub 2017 Dec 28.

Abstract

Alzheimer's disease (AD) is a disabling and highly prevalent neurodegenerative condition, for which there are no effective therapies. Soluble oligomers of the amyloid-β peptide (AβOs) are thought to be proximal neurotoxins involved in early neuronal oxidative stress and synapse damage, ultimately leading to neurodegeneration and memory impairment in AD. The aim of the current study was to evaluate the neuroprotective potential of mesenchymal stem cells (MSCs) against the deleterious impact of AβOs on hippocampal neurons. To this end, we established transwell cocultures of rat hippocampal neurons and MSCs. We show that MSCs and MSC-derived extracellular vesicles protect neurons against AβO-induced oxidative stress and synapse damage, revealed by loss of pre- and postsynaptic markers. Protection by MSCs entails three complementary mechanisms: 1) internalization and degradation of AβOs; 2) release of extracellular vesicles containing active catalase; and 3) selective secretion of interleukin-6, interleukin-10, and vascular endothelial growth factor to the medium. Results support the notion that MSCs may represent a promising alternative for cell-based therapies in AD.

摘要

阿尔茨海默病(AD)是一种使人衰弱且高度流行的神经退行性疾病,目前尚无有效的治疗方法。淀粉样β肽(AβOs)的可溶性低聚物被认为是与早期神经元氧化应激和突触损伤有关的近端神经毒素,最终导致 AD 中的神经退行性变和记忆损伤。本研究旨在评估间充质干细胞(MSCs)对 AβOs 对海马神经元的有害影响的神经保护潜力。为此,我们建立了大鼠海马神经元和 MSCs 的 Transwell 共培养物。我们表明,MSCs 和 MSC 衍生的细胞外囊泡通过丢失突触前和突触后标志物来保护神经元免受 AβO 诱导的氧化应激和突触损伤。MSCs 的保护作用涉及三种互补机制:1)AβOs 的内化和降解;2)包含活性过氧化氢酶的细胞外囊泡的释放;和 3)白细胞介素-6、白细胞介素-10 和血管内皮生长因子到培养基中的选择性分泌。研究结果支持这样一种观点,即 MSCs 可能代表 AD 中基于细胞的治疗的有前途的替代方法。

相似文献

3
Interaction of amyloid-β (Aβ) oligomers with neurexin 2α and neuroligin 1 mediates synapse damage and memory loss in mice.
J Biol Chem. 2017 May 5;292(18):7327-7337. doi: 10.1074/jbc.M116.761189. Epub 2017 Mar 10.
4
Astrocyte Transforming Growth Factor Beta 1 Protects Synapses against Aβ Oligomers in Alzheimer's Disease Model.
J Neurosci. 2017 Jul 12;37(28):6797-6809. doi: 10.1523/JNEUROSCI.3351-16.2017. Epub 2017 Jun 12.
7
Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
Acta Neuropathol. 2015 Feb;129(2):183-206. doi: 10.1007/s00401-015-1386-3. Epub 2015 Jan 22.
9
The soluble extracellular fragment of neuroligin-1 targets Aβ oligomers to the postsynaptic region of excitatory synapses.
Biochem Biophys Res Commun. 2015 Oct 9;466(1):66-71. doi: 10.1016/j.bbrc.2015.08.107. Epub 2015 Aug 29.
10
Inhibition of choline acetyltransferase as a mechanism for cholinergic dysfunction induced by amyloid-β peptide oligomers.
J Biol Chem. 2012 Jun 1;287(23):19377-85. doi: 10.1074/jbc.M111.321448. Epub 2012 Apr 13.

引用本文的文献

1
Stem cell therapy offers new hope for the treatment of Alzheimer's disease.
Front Cell Dev Biol. 2025 Aug 14;13:1650885. doi: 10.3389/fcell.2025.1650885. eCollection 2025.
3
Extracellular Vesicles for the Treatment of Alzheimer's Disease: A Systematic Review.
J Extracell Biol. 2025 Aug 20;4(8):e70077. doi: 10.1002/jex2.70077. eCollection 2025 Aug.
5
Stem cell extracellular vesicles: a new dawn for anti-inflammatory treatment of neurodegenerative diseases.
Front Aging Neurosci. 2025 Jul 11;17:1592578. doi: 10.3389/fnagi.2025.1592578. eCollection 2025.
7
Mesenchymal stem cell-derived exosomes as a potential therapeutic strategy for ferroptosis.
Stem Cell Res Ther. 2025 Jul 15;16(1):368. doi: 10.1186/s13287-025-04511-2.
8
Mesenchymal Stem Cell-Derived Extracellular Vesicles: Emerging Therapies for Neurodegenerative Diseases.
Int J Nanomedicine. 2025 Jul 2;20:8547-8565. doi: 10.2147/IJN.S526945. eCollection 2025.
10
Research progress of extracellular vesicles derived from mesenchymal stem cells in the treatment of neurodegenerative diseases.
Front Immunol. 2025 Apr 2;16:1496304. doi: 10.3389/fimmu.2025.1496304. eCollection 2025.

本文引用的文献

1
Extracellular Vesicle Isolation and Analysis by Western Blotting.
Methods Mol Biol. 2017;1660:143-152. doi: 10.1007/978-1-4939-7253-1_12.
3
Cellular prion protein as a receptor for amyloid-β oligomers in Alzheimer's disease.
Biochem Biophys Res Commun. 2017 Feb 19;483(4):1143-1147. doi: 10.1016/j.bbrc.2016.09.062. Epub 2016 Sep 14.
4
Association of interleukin-10 polymorphisms with risk factors of Alzheimer's disease and other dementias (SADEM study).
Immunol Lett. 2016 Sep;177:47-52. doi: 10.1016/j.imlet.2016.07.011. Epub 2016 Jul 26.
5
Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease.
Radiology. 2016 Nov;281(2):527-535. doi: 10.1148/radiol.2016152244. Epub 2016 May 31.
7
Effect of systemic transplantation of bone marrow-derived mesenchymal stem cells on neuropathology markers in APP/PS1 Alzheimer mice.
Neuropathol Appl Neurobiol. 2017 Jun;43(4):299-314. doi: 10.1111/nan.12319. Epub 2016 Apr 19.
9
KCC2 rescues functional deficits in human neurons derived from patients with Rett syndrome.
Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):751-6. doi: 10.1073/pnas.1524013113. Epub 2016 Jan 5.
10
Proteomics of cell-cell interactions in health and disease.
Proteomics. 2016 Jan;16(2):328-44. doi: 10.1002/pmic.201500341. Epub 2015 Dec 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验